Trillium Asset Management’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.08M Buy
37,411
+9,534
+34% +$1.24M 0.14% 121
2025
Q4
$3.53M Sell
27,877
-5,656
-17% -$710K 0.11% 131
2025
Q3
$3.76M Sell
33,533
-501
-1% -$58.6K 0.1% 135
2025
Q2
$4.56M Sell
34,034
-1,355
-4% -$149K 0.12% 126
2025
Q1
$2.38M Buy
35,389
+2,442
+7% +$168K 0.07% 148
2024
Q4
$2.05M Buy
32,947
+9,718
+42% +$905K 0.05% 157
2024
Q3
$3.65M Sell
23,229
-75
-0.3% -$11.6K 0.09% 154
2024
Q2
$3.51M Buy
+23,304
New +$2.8M 0.09% 154

Other funds holding TMDX

Trillium Asset Management's TMDX Position: Q1 2026 in Review

Trillium Asset Management increased its Transmedics (TMDX) stake by 34% in Q1 2026, buying an estimated $1.24M and bringing the position to 37,411 shares worth $4.08M. The position accounts for 0.14% of the portfolio, ranked #121.

Trillium Asset Management first reported a position in TMDX in Q2 2024 and has held it in 8 quarters since. The position peaked at $4.56M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Trillium Asset Management held 37,411 shares of Transmedics worth $4.08M as of Q1 2026.
  • Trillium Asset Management bought 9,534 Transmedics shares in Q1 2026, an estimated $1.24M.
  • Transmedics made up 0.14% of Trillium Asset Management's portfolio in Q1 2026, its #121 holding.
  • Trillium Asset Management first reported a position in Transmedics in Q2 2024 and has held it in 8 quarters since.
  • Trillium Asset Management's Transmedics position peaked at $4.56M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Trillium Asset Management's 13F filing for Q1 2026, filed 11 May 2026.